A previous study demonstrated that one of our tested ceRNA pathways, RPPH1/miR-330-5p/CDC42, may be involved in the compensatory behaviour of brain neurons to combat synaptic loss during AD pathogenesis [18]. This evidence concerns the gene CDC42 and Alzheimer disease.